S2G Ventures

Solarea Bio, Inc. is a biotech company based in Cambridge, Massachusetts, established in 2017. The company specializes in the development of microbial therapeutics aimed at addressing health issues related to chronic inflammation. By harnessing bacteria and fungi derived from healthy foods, Solarea creates synergistic microbial assemblages with anti-inflammatory properties. It maintains a comprehensive genomic database of these microbes and employs computational methods to generate combinations of bacteria, fungi, and prebiotic fibers tailored to treat specific conditions. Solarea's research has demonstrated the effectiveness of its products in preclinical models. Its initial focus is on dietary management solutions for metabolic processes associated with osteopenia and osteoporosis in postmenopausal women, providing a nature-based approach to enhance women's health and well-being.

Brightseed, Inc. is a biotechnology company that specializes in discovering clinically beneficial molecules found in plants through its innovative Forager platform. Founded in 2017 and based in San Francisco, California, the company employs artificial intelligence and machine learning algorithms to screen plant genes, identifying the most effective sources for addressing various health conditions. By uncovering naturally occurring compounds with potential health benefits, Brightseed aims to enhance the quality of life and support chronic disease management. The company’s mission is to strengthen the connection between people and plants, ultimately facilitating a healthier future for individuals and communities.

Yali Biosciences is a food tech company that uses synthetic biology and genomics tools to make climate-smart, sustainable foods.

GreenLight Biosciences is a biotechnology company that specializes in RNA-based solutions for agricultural and pharmaceutical applications. Founded in 2008 and headquartered in Medford, Massachusetts, with an additional location in North Carolina, the company utilizes its Unconstrained Metabolism technology platform to convert renewable substrates into valuable chemicals and fuels. This platform allows for significant flexibility and control in the production process. GreenLight is also focused on developing RNA products aimed at improving crop management, plant protection, and animal health, while advancing vaccine development and pandemic preparedness. In addition to these applications, the company is working on mRNA-based vaccine candidates targeting seasonal and pandemic influenza, as well as other emerging viruses, to enhance public health. Through its innovations, GreenLight aims to provide sustainable solutions that contribute to global food security and health.

3Bar Biologics Inc. is a bioscience company located in Columbus, Ohio, focused on enhancing agricultural productivity through innovative solutions. Established in 2013, the company specializes in the development of Bio-YIELD, a microbe inoculant system that utilizes naturally occurring microbes tailored to specific crops and soil conditions. This all-natural product aims to increase crop yields and produce healthier plants by employing beneficial microorganisms. Bio-YIELD was first introduced to farmers in the eastern Corn Belt in 2014 and is supported by over 15 years of research conducted by scientists at The Ohio State University. The firm is committed to expanding its reach to global markets as it gathers further data to support its products, promoting sustainable farming practices that protect farmers' investments in their land and seeds.

Sound Agriculture Company develops innovative crop protection and enhancement products aimed at improving agricultural yields and farm revenues while addressing challenges such as drought. The company offers Source, a solution that enhances in-season nutrient uptake by unlocking existing nitrogen and phosphorus in the soil, thereby helping growers optimize crop performance sustainably. Additionally, Sound Agriculture focuses on improving photosynthesis, water capture, and crop efficiency, contributing to healthier and more flavorful food while reducing waste. Founded in 2012 and based in Emeryville, California, the company employs molecular discovery and life science approaches to create climate-resilient crops, ultimately enhancing productivity for farmers. Originally known as Asilomar Bio, Inc., it rebranded to Sound Agriculture Company in September 2018.

ViAqua Therapeutics Ltd, founded in 2014 and based in Misgav, Israel, specializes in developing innovative therapeutics for the aquaculture industry. The company focuses on addressing viral epidemics that threaten aquatic species, particularly shrimp. Its flagship product is an orally administered, particle-based platform that employs a proprietary RNAi nanoparticle formulation. This formulation prompts a cellular response to inhibit viral infections and is delivered through feed or immersion methods. By enhancing disease resistance, ViAqua Therapeutics aims to support the aquaculture sector in managing and preventing viral diseases, ultimately contributing to the sustainability and productivity of aquaculture operations.

Solarea Bio, Inc. is a biotech company based in Cambridge, Massachusetts, established in 2017. The company specializes in the development of microbial therapeutics aimed at addressing health issues related to chronic inflammation. By harnessing bacteria and fungi derived from healthy foods, Solarea creates synergistic microbial assemblages with anti-inflammatory properties. It maintains a comprehensive genomic database of these microbes and employs computational methods to generate combinations of bacteria, fungi, and prebiotic fibers tailored to treat specific conditions. Solarea's research has demonstrated the effectiveness of its products in preclinical models. Its initial focus is on dietary management solutions for metabolic processes associated with osteopenia and osteoporosis in postmenopausal women, providing a nature-based approach to enhance women's health and well-being.

Brightseed, Inc. is a biotechnology company that specializes in discovering clinically beneficial molecules found in plants through its innovative Forager platform. Founded in 2017 and based in San Francisco, California, the company employs artificial intelligence and machine learning algorithms to screen plant genes, identifying the most effective sources for addressing various health conditions. By uncovering naturally occurring compounds with potential health benefits, Brightseed aims to enhance the quality of life and support chronic disease management. The company’s mission is to strengthen the connection between people and plants, ultimately facilitating a healthier future for individuals and communities.

GreenLight Biosciences is a biotechnology company that specializes in RNA-based solutions for agricultural and pharmaceutical applications. Founded in 2008 and headquartered in Medford, Massachusetts, with an additional location in North Carolina, the company utilizes its Unconstrained Metabolism technology platform to convert renewable substrates into valuable chemicals and fuels. This platform allows for significant flexibility and control in the production process. GreenLight is also focused on developing RNA products aimed at improving crop management, plant protection, and animal health, while advancing vaccine development and pandemic preparedness. In addition to these applications, the company is working on mRNA-based vaccine candidates targeting seasonal and pandemic influenza, as well as other emerging viruses, to enhance public health. Through its innovations, GreenLight aims to provide sustainable solutions that contribute to global food security and health.

Sound Agriculture Company develops innovative crop protection and enhancement products aimed at improving agricultural yields and farm revenues while addressing challenges such as drought. The company offers Source, a solution that enhances in-season nutrient uptake by unlocking existing nitrogen and phosphorus in the soil, thereby helping growers optimize crop performance sustainably. Additionally, Sound Agriculture focuses on improving photosynthesis, water capture, and crop efficiency, contributing to healthier and more flavorful food while reducing waste. Founded in 2012 and based in Emeryville, California, the company employs molecular discovery and life science approaches to create climate-resilient crops, ultimately enhancing productivity for farmers. Originally known as Asilomar Bio, Inc., it rebranded to Sound Agriculture Company in September 2018.

NewLeaf Symbiotics, Inc. is a research-driven company based in Saint Louis, Missouri, specializing in the development and commercialization of beneficial symbiotic bacteria to enhance plant health and increase crop yields. The company focuses on Pink Pigmented Facultative Methylotrophs (PPFMs), which are natural bacteria beneficial to various agricultural sectors, including row crops, vegetables, fruits, and flowers. NewLeaf conducts extensive laboratory, greenhouse, and field trials to validate and refine its products, which are designed to help farmers combat plant diseases sustainably. Established in 2011 and previously known as TrophoMax, NewLeaf aims to innovate and expand its offerings through ongoing research and the filing of related patents, with the goal of commercializing its products.

Brightseed, Inc. is a biotechnology company that specializes in discovering clinically beneficial molecules found in plants through its innovative Forager platform. Founded in 2017 and based in San Francisco, California, the company employs artificial intelligence and machine learning algorithms to screen plant genes, identifying the most effective sources for addressing various health conditions. By uncovering naturally occurring compounds with potential health benefits, Brightseed aims to enhance the quality of life and support chronic disease management. The company’s mission is to strengthen the connection between people and plants, ultimately facilitating a healthier future for individuals and communities.

GreenLight Biosciences is a biotechnology company that specializes in RNA-based solutions for agricultural and pharmaceutical applications. Founded in 2008 and headquartered in Medford, Massachusetts, with an additional location in North Carolina, the company utilizes its Unconstrained Metabolism technology platform to convert renewable substrates into valuable chemicals and fuels. This platform allows for significant flexibility and control in the production process. GreenLight is also focused on developing RNA products aimed at improving crop management, plant protection, and animal health, while advancing vaccine development and pandemic preparedness. In addition to these applications, the company is working on mRNA-based vaccine candidates targeting seasonal and pandemic influenza, as well as other emerging viruses, to enhance public health. Through its innovations, GreenLight aims to provide sustainable solutions that contribute to global food security and health.

GreenLight Biosciences is a biotechnology company that specializes in RNA-based solutions for agricultural and pharmaceutical applications. Founded in 2008 and headquartered in Medford, Massachusetts, with an additional location in North Carolina, the company utilizes its Unconstrained Metabolism technology platform to convert renewable substrates into valuable chemicals and fuels. This platform allows for significant flexibility and control in the production process. GreenLight is also focused on developing RNA products aimed at improving crop management, plant protection, and animal health, while advancing vaccine development and pandemic preparedness. In addition to these applications, the company is working on mRNA-based vaccine candidates targeting seasonal and pandemic influenza, as well as other emerging viruses, to enhance public health. Through its innovations, GreenLight aims to provide sustainable solutions that contribute to global food security and health.

NewLeaf Symbiotics, Inc. is a research-driven company based in Saint Louis, Missouri, specializing in the development and commercialization of beneficial symbiotic bacteria to enhance plant health and increase crop yields. The company focuses on Pink Pigmented Facultative Methylotrophs (PPFMs), which are natural bacteria beneficial to various agricultural sectors, including row crops, vegetables, fruits, and flowers. NewLeaf conducts extensive laboratory, greenhouse, and field trials to validate and refine its products, which are designed to help farmers combat plant diseases sustainably. Established in 2011 and previously known as TrophoMax, NewLeaf aims to innovate and expand its offerings through ongoing research and the filing of related patents, with the goal of commercializing its products.